ArticleJournal of clinical pharmacology2016

Phase 1 Study of ABT-751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer.

Michelle A Rudek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.